newborn screening for sma scid Market Growth Drivers & Forecast 2033

newborn screening for sma scid by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

newborn screening for sma scid Market Size | CAGR 15.2 Forecast 2033

newborn screening for sma scid Market Growth Drivers & Forecast 2033

newborn screening for sma scid by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 84

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

newborn screening for sma scid Market Overview

The newborn screening for SMA SCID market refers to the testing of newborns for Spinal Muscular Atrophy (SMA) and Severe Combined Immunodeficiency (SCID), two serious genetic disorders. As the newborn screening for SMA SCID market size is estimated to be around $1.4 billion in 2025, the growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by increasing awareness and advancements in screening technologies, ultimately contributing to the industry expansion. The scope of this market encompasses the diagnosis and treatment of SMA and SCID in newborns, including molecular testing, genetic counseling, and enzyme replacement therapy.

Loading chart…

The newborn screening for SMA SCID market is expected to grow at a compound annual growth rate (CAGR) of 8%, driven by macro drivers such as increasing awareness, advancements in screening technologies, and government initiatives. Key forces shaping the industry include technology shifts towards non-invasive and cost-effective screening methods, regulations supporting the implementation of newborn screening programs, and competitive intensity among market players. The largest region for this market is North America, while the fastest-growing region is Asia-Pacific. As the market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to capitalize on emerging opportunities.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Roche Diagnostics; Illumina, Inc.; Bio-Rad Laboratories, Inc.; Quest Diagnostics Incorporated; Laboratory Corporation of America Holdings; Agilent Technologies, Inc.; Siemens Healthineers AG; BGI Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The newborn screening for sma scid market is poised for significant growth, driven by increasing awareness and advancements in screening technologies. The newborn screening for sma scid market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in genetic testing technologies, such as next-generation sequencing, are enhancing the accuracy and efficiency of newborn screening for SMA and SCID, driving market growth

Government initiatives and mandates for newborn screening programs are expanding, increasing the demand for SMA and SCID screening tests and contributing to the newborn screening for sma scid market expansion

Restraints2 items

High costs associated with newborn screening tests, particularly for SMA and SCID, may limit accessibility in resource-constrained settings, hindering market growth

Complexities in test interpretation and variability in screening protocols across different regions may impede the adoption of newborn screening for SMA and SCID, affecting the newborn screening for sma scid market size

Opportunities2 items

Emerging markets, particularly in Asia Pacific and Latin America, present significant opportunities for the expansion of newborn screening for SMA and SCID, driven by increasing awareness and improving healthcare infrastructure

The development of point-of-care and non-invasive screening tests for SMA and SCID offers opportunities for market players to introduce innovative products, enhancing the growth forecast of the newborn screening for sma scid market

Challenges2 items

Ensuring the standardization of newborn screening protocols for SMA and SCID across different regions and countries remains a significant challenge, impacting the newborn screening for sma scid market

Addressing ethical concerns related to genetic testing, such as informed consent and data privacy, is crucial for the widespread adoption of newborn screening for SMA and SCID, influencing the newborn screening for sma scid market size

Market Segmentation

Loading chart…

The newborn screening for sma scid market can be segmented into various categories based on application. One key segment is the hospitals and clinics sector, which accounts for a significant portion of the market size. This segment contributes to the overall market size by providing screening services to newborns, thereby driving the demand for sma scid screening tests. As a result, the newborn screening for sma scid segmentation is crucial in understanding the market trends and growth prospects.

Another significant segment is the laboratories sector, which plays a vital role in the newborn screening for sma scid market. This segment involves the use of specialized equipment and testing kits to diagnose sma scid in newborns. The laboratories segment contributes to the overall market size by providing accurate and reliable test results, thereby enabling healthcare professionals to make informed decisions about patient care. Furthermore, the market taxonomy of newborn screening for sma scid highlights the importance of laboratories in the overall market landscape.

The public health organizations segment is also a critical component of the newborn screening for sma scid market. This segment involves government-funded initiatives and programs aimed at promoting newborn screening for sma scid. Public health organizations contribute to the overall market size by raising awareness about the importance of newborn screening and providing funding for screening programs. As a result, the newborn screening for sma scid segmentation by application is essential in understanding the market dynamics and growth prospects.

Regional Insights

Loading chart…

The newborn screening for sma scid market is expected to witness significant growth in the coming years, driven by increasing adoption and investments in various regions. North America is the largest region, accounting for approximately 40% of the market share, driven by factors such as established infrastructure, high ecosystem maturity, and favorable policies. The region is followed by Europe, which holds around 30% of the market share, driven by growing demographics and increasing adoption of newborn screening programs.

The fastest-growing region is expected to be Asia Pacific, driven by increasing investments in healthcare infrastructure, growing demographics, and rising awareness about the importance of newborn screening. The region is expected to grow at a significant rate, driven by key drivers such as government initiatives, increasing infrastructure, and growing ecosystem maturity. Latin America and Middle East & Africa are also expected to witness significant growth, driven by increasing adoption and growing demographics.

Key Drivers for Each Region5 items

North America: established infrastructure, high ecosystem maturity, and favorable policies

Europe: growing demographics, increasing adoption, and established healthcare system

Asia Pacific: increasing investments in healthcare infrastructure, growing demographics, and rising awareness

Latin America: increasing adoption, growing demographics, and government initiatives

Middle East & Africa: growing demographics, increasing adoption, and rising awareness

Competitive Landscape

The newborn screening for sma scid market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The market structure is characterized by a high level of competition, with companies vying for market share in the newborn screening for sma scid competitive landscape. Global players have a significant presence, but local companies are also gaining traction, particularly in emerging markets.

Companies in this market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Key differentiators include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies are focusing on strategic initiatives such as:

Thermo Fisher Scientific Inc. - regional expansion

PerkinElmer Inc. - innovation pipeline

Roche Diagnostics - premium pricing

Illumina, Inc. - OEM tie-ups

Bio-Rad Laboratories, Inc. - local manufacturing

Quest Diagnostics Incorporated - vertical integration

Key newborn screening for sma scid Companies10 items

Thermo Fisher Scientific Inc.

PerkinElmer Inc.

Roche Diagnostics

Illumina, Inc.

Bio-Rad Laboratories, Inc.

Quest Diagnostics Incorporated

Laboratory Corporation of America Holdings

Agilent Technologies, Inc.

Siemens Healthineers AG

BGI Group

Market Ecosystem

The newborn screening for sma scid ecosystem encompasses a complex network of participants, from upstream technology providers to downstream end users. This ecosystem can be broadly categorized into three segments: upstream, midstream, and downstream, with value created and captured at each stage. Upstream participants, such as technology providers and suppliers, contribute to the development of screening technologies, while midstream integrators and channels facilitate the integration and distribution of these technologies. Downstream end users, including hospitals and healthcare providers, ultimately adopt and utilize these screening solutions.

Technology providers — develop screening technologies

OEMs / manufacturers — produce screening equipment

System integrators / EPCs — integrate screening systems

Distributors / channel partners — distribute screening solutions

Service providers / after-sales — offer maintenance and support

End users / buyers — adopt and utilize screening solutions

Regulators/standards bodies — establish screening standards and guidelines

In the newborn screening for sma scid ecosystem, value flows through the creation and capture of innovative screening technologies, effective integration and distribution channels, and ultimately, the adoption and utilization of these solutions by end users. Control points, such as regulatory approvals and standards, influence the adoption of screening technologies, while dependency risks, including input constraints and interoperability requirements, can impact the ecosystem's efficiency. A thorough value chain analysis of this ecosystem can help identify potential bottlenecks and areas for improvement, particularly in regions with diverse regulatory frameworks and healthcare infrastructure.

Recent Industry Insights

The newborn screening for sma scid industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between biotechnology companies and research institutions, have accelerated the development of innovative screening technologies. Additionally, there have been notable mergers and acquisitions, with key players expanding their portfolios to include SMA and SCID screening solutions.

Furthermore, the launch of novel products and technologies, such as next-generation sequencing and machine learning-based diagnostic tools, has improved the accuracy and efficiency of newborn screening for SMA and SCID. Regulatory changes, including the implementation of mandatory screening programs in several countries, have also driven growth in the market. These developments are expected to continue shaping the newborn screening for sma scid industry trends, with a focus on increasing access to early diagnosis and treatment.

Analyst Overview

As the Lead Analyst, I provide an expert view on the newborn screening for sma scid market outlook. The market attractiveness is moderate, driven by increasing awareness and advancements in screening technologies. The competitive intensity is relatively low, with a few key players dominating the market. The long-term outlook is positive, with growing demand for early diagnosis and treatment of SMA and SCID.

The innovation landscape is evolving, with ongoing research and development of new screening methods and technologies. The demand-supply balance is expected to be stable, with increasing demand met by expanding supply from existing and new market entrants. However, key risk factors include regulatory changes, reimbursement challenges, and limited awareness in certain regions, which may impact market growth.

11 items

1. Executive Summary

2. newborn screening for sma scid Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global newborn screening for sma scid Market Outlook & Forecast (2021-2033) Value (USD Million)

7. Global newborn screening for sma scid Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global newborn screening for sma scid Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

8. Global newborn screening for sma scid Market Competition by Key Manufacturers

8.1. Global newborn screening for sma scid Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global newborn screening for sma scid: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific Inc.

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. PerkinElmer Inc.

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Roche Diagnostics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Illumina, Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bio-Rad Laboratories, Inc.

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Quest Diagnostics Incorporated

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Laboratory Corporation of America Holdings

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Agilent Technologies, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Siemens Healthineers AG

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BGI Group

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

16 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global newborn screening for sma scid Market

Figure 4: Global newborn screening for sma scid Market: Drivers

Figure 5: Global newborn screening for sma scid Market: Challenges

Figure 6: Global newborn screening for sma scid Market: Trends

Figure 7: Global newborn screening for sma scid Market: Opportunity

Figure 8: Global newborn screening for sma scid Market: Restraint

Figure 9: Global newborn screening for sma scid Market: Porter's Five Forces

Figure 10: Global newborn screening for sma scid Market Value (USD Million) By Region

Figure 11: Global newborn screening for sma scid Market Share (%) By: Regions (2024)

Figure 12: Top 5 Manufacturers

Figure 13: Top 3 Manufacturers

Figure 14: Global newborn screening for sma scid Market Value (USD Million) By Region

Figure 15: Global newborn screening for sma scid Market Share (%) By: Regions (2032)

Figure 16: Data Triangulation

List of Tables

43 items

Table 1: Market Segmentation Analysis

Table 2: Global newborn screening for sma scid Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 3: Global newborn screening for sma scid Market Value (USD Million) By Region

Table 4: Global newborn screening for sma scid Market Share (%) By Region

Table 5: North America Market Value (USD Million) (2020-2024) By Country

Table 6: Europe Market Value (USD Million) (2020-2024) By Country

Table 7: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 8: South America Market Value (USD Million) (2020-2024) By Country

Table 9: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 10: Global newborn screening for sma scid Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 11: Global newborn screening for sma scid Market: Profiled Players Head Office And Area Served

Table 12: Key Players Global newborn screening for sma scid Market:

Table 13: Mergers & Acquisitions, Expansion Plans

Table 14: Thermo Fisher Scientific Inc. Basic Information And Sales Area

Table 15: Thermo Fisher Scientific Inc.. Products Portfolio

Table 16: PerkinElmer Inc. Basic Information And Sales Area

Table 17: PerkinElmer Inc.. Products Portfolio

Table 18: Roche Diagnostics Basic Information And Sales Area

Table 19: Roche Diagnostics. Products Portfolio

Table 20: Illumina, Inc. Basic Information And Sales Area

Table 21: Illumina, Inc.. Products Portfolio

Table 22: Bio-Rad Laboratories, Inc. Basic Information And Sales Area

Table 23: Bio-Rad Laboratories, Inc.. Products Portfolio

Table 24: Quest Diagnostics Incorporated Basic Information And Sales Area

Table 25: Quest Diagnostics Incorporated. Products Portfolio

Table 26: Laboratory Corporation of America Holdings Basic Information And Sales Area

Table 27: Laboratory Corporation of America Holdings. Products Portfolio

Table 28: Agilent Technologies, Inc. Basic Information And Sales Area

Table 29: Agilent Technologies, Inc.. Products Portfolio

Table 30: Siemens Healthineers AG Basic Information And Sales Area

Table 31: Siemens Healthineers AG. Products Portfolio

Table 32: BGI Group Basic Information And Sales Area

Table 33: BGI Group. Products Portfolio

Table 34: Global newborn screening for sma scid Market Value (USD Million) By Region

Table 35: Global newborn screening for sma scid Market Share (%) By Region (2025-2032)

Table 36: North America Market Value (USD Million) (2025-2032) By Country

Table 37: Europe Market Value (USD Million) (2025-2032) By Country

Table 38: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 39: South America Market Value (USD Million) (2025-2032) By Country

Table 40: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 41: Research Programs/Design For This Report

Table 42: Key Data Information From Secondary Sources

Table 43: Key Data Information From Primary Sources

FAQs

1. What is the current newborn screening for sma scid market size?

The current market size is approximately USD 1.2 billion as of 2023, driven by advancements in screening technologies.

2. What is the expected growth forecast for the newborn screening market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing awareness and adoption.

3. What are the key drivers of the newborn screening for sma scid market?

Key drivers include government initiatives, technological advancements, and rising demand for early disease detection and treatment.

4. What are the major challenges facing the newborn screening for sma scid market?

Challenges include high costs, limited awareness, and lack of standardization in screening protocols and procedures.

5. Which regions are leading the newborn screening for sma scid market?

North America and Europe are leading the market, driven by well-established healthcare infrastructure and high adoption rates.

6. Who are the top companies in the newborn screening for sma scid market?

Top companies include PerkinElmer, Bio-Rad, and Thermo Fisher, offering a range of screening products and services.

7. What are the future opportunities in the newborn screening for sma scid market?

Future opportunities include emerging markets, advancements in genetic testing, and increasing focus on personalized medicine and targeted therapies.

8. How is technology impacting the newborn screening for sma scid market?

Technology is driving innovation, improving test accuracy, and enabling faster results, with next-generation sequencing and AI-powered diagnostics on the horizon.

9. What is the current regulatory landscape for newborn screening?

The regulatory landscape is evolving, with increasing focus on standardization, quality control, and patient data protection, driving market growth and innovation.

10. What is the future outlook for the newborn screening for sma scid market?

The future outlook is positive, with growing demand, advancing technologies, and increasing investment in research and development driving market expansion.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

newborn screening for sma scid Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	3.72 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Light source type, interior design, application, end use, region
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific Inc.; PerkinElmer Inc.; Roche Diagnostics; Illumina, Inc.; Bio-Rad Laboratories, Inc.; Quest Diagnostics Incorporated; Laboratory Corporation of America Holdings; Agilent Technologies, Inc.; Siemens Healthineers AG; BGI Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options